These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 19701545)

  • 1. Earlier administration of high-dose bolus tirofiban in STEMI increases benefit without increasing bleeding complications.
    Cardiovasc J Afr; 2009; 20(4):268. PubMed ID: 19701545
    [No Abstract]   [Full Text] [Related]  

  • 2. Current strategies with high-dose tirofiban.
    Mukherjee D; Roffi M
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):275-80. PubMed ID: 17428156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of tirofiban for failed thrombolysis during acute myocardial infarction.
    Vetrano A; Carotenuto R; Corsini F; Schioppa M; Martone A; Melorio S; Sideri F; Romano S; Chieffo C; Corsini G
    Am J Cardiol; 2004 Apr; 93(7):914-6. PubMed ID: 15050497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein IIb/IIIa inhibition and long-term benefit: the stuff of dreams?
    Montalescot G
    Eur Heart J; 2004 Sep; 25(18):1562-4. PubMed ID: 15351154
    [No Abstract]   [Full Text] [Related]  

  • 5. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):683-90. PubMed ID: 19751625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nothing is lower than 0, and 3 is closer to 0 than to 5 - medicine is not arithmetic.
    Colombo A; Stankovic G
    Eur Heart J; 2002 Jun; 23(11):840-2. PubMed ID: 12042003
    [No Abstract]   [Full Text] [Related]  

  • 7. Complicated acute myocardial infarction.
    Reisner AT; Binder WD; Nadel ES; Brown DF
    J Emerg Med; 2001 Jan; 20(1):73-9. PubMed ID: 11165841
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and biological evaluation of PEG-tirofiban conjugates.
    Désaubry L; Riché S; Laeuffer P; Cazenave JP
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2028-31. PubMed ID: 18304813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality-adjusted life-years as decisionmaker tools to address limitations inherent in number-needed-to-treat/harm values.
    Raisch DW; Nawarskas JJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Apr; 9(2):99-102. PubMed ID: 19402794
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute coronary syndromes.
    Cequier A; Gómez-Hospital JA; Gonzalez-Costello J
    N Engl J Med; 2009 Aug; 361(9):926; author reply 927. PubMed ID: 19714783
    [No Abstract]   [Full Text] [Related]  

  • 11. 22nd congress of the European Society of Cardiology, Amsterdam.
    Wroe CD
    Int J Clin Pract; 2000 Sep; 54(7):459-60. PubMed ID: 11202979
    [No Abstract]   [Full Text] [Related]  

  • 12. Coexistence of cardiomyopathy and pericardial effusion: A challenging diagnosis. Reply.
    Omar HR
    Herz; 2014 Mar; 39(2):225. PubMed ID: 24812687
    [No Abstract]   [Full Text] [Related]  

  • 13. Coexistence of cardiomyopathy and pericardial effusion: A challenging diagnosis.
    Yalcinkaya E
    Herz; 2014 Mar; 39(2):224. PubMed ID: 24154881
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myocardial infarction 2009--Randomized studies vs. clinical daily routine].
    Zeymer U; Zahn R; Gitt A; Schneider S; Senges J
    Dtsch Med Wochenschr; 2009 Oct; 134 Suppl 6():S190-1. PubMed ID: 19834837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction.
    Ahrens I; Peter K
    Curr Opin Investig Drugs; 2009 Sep; 10(9):997-1003. PubMed ID: 19705343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction Systematic overview and meta-analysis.
    Vorobcsuk A; Kónyi A; Aradi D; Horváth IG; Ungi I; Louvard Y; Komócsi A
    Am Heart J; 2009 Nov; 158(5):814-21. PubMed ID: 19853703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doing more good than harm: need for a cease fire.
    Hennekens CH; DeMets DL; Bairey Merz CN; Borzak SL; Borer JS
    Am J Med; 2009 Apr; 122(4):315-6. PubMed ID: 19332222
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study.
    Marcoff L; Zhang Z; Zhang W; Ewen E; Jurkovitz C; Leguet P; Kolm P; Weintraub WS
    J Am Coll Cardiol; 2009 Sep; 54(14):1271-9. PubMed ID: 19778669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet function testing and implications for clinical practice.
    Collet JP; Montalescot G
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.